{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T16:13:15Z","timestamp":1782576795653,"version":"3.54.5"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Netherlands Organization for Health Research and Development Zon-MWTOP grant","award":["91212044"],"award-info":[{"award-number":["91212044"]}]},{"name":"Erasmus Medical Center Medical Research Advisory Committee grant"},{"name":"Lecture fees from IBSA and Goodlife Fertility"},{"name":"Netherlands Organization for Scientific Research VENI grant","award":["91616079"],"award-info":[{"award-number":["91616079"]}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002957","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T17:33:52Z","timestamp":1572024832000},"page":"e1002957","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Thyroid function and life expectancy with and without noncommunicable diseases: A\u00a0population-based study"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0956-7145","authenticated-orcid":true,"given":"Arjola","family":"Bano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layal","family":"Chaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco U. S.","family":"Mattace-Raso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Terzikhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Kavousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0372-8585","authenticated-orcid":true,"given":"M. Arfan","family":"Ikram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin P.","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar H.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"key":"pmed.1002957.ref001","volume-title":"Chronic Disease: An Economic Perspective","author":"M Suhrcke","year":"2006"},{"key":"pmed.1002957.ref002","author":"WHO","year":"2014"},{"issue":"10053","key":"pmed.1002957.ref003","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(16)31679-8","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"GBD 2015 Risk Factors Collaborators","year":"2016","journal-title":"Lancet"},{"issue":"9859","key":"pmed.1002957.ref004","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"CJ Murray","year":"2012","journal-title":"Lancet"},{"issue":"12","key":"pmed.1002957.ref005","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/jama.2010.1361","article-title":"Subclinical hypothyroidism and the risk of coronary heart disease and mortality","volume":"304","author":"N Rodondi","year":"2010","journal-title":"JAMA"},{"issue":"10","key":"pmed.1002957.ref006","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/archinternmed.2012.402","article-title":"Subclinical hyperthyroidism and the risk of coronary heart disease and mortality","volume":"172","author":"TH Collet","year":"2012","journal-title":"Archives of internal medicine"},{"issue":"9","key":"pmed.1002957.ref007","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/CIRCULATIONAHA.112.096024","article-title":"Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts","volume":"126","author":"B Gencer","year":"2012","journal-title":"Circulation"},{"issue":"2","key":"pmed.1002957.ref008","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1158\/1055-9965.EPI-08-0911","article-title":"Thyroid function and cancer risk: a prospective population study","volume":"18","author":"AI Hellevik","year":"2009","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"issue":"9","key":"pmed.1002957.ref009","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2337\/dc14-2515","article-title":"Hypothyroidism is a Risk Factor for New-Onset Diabetes: A Cohort Study","volume":"38","author":"N Gronich","year":"2015","journal-title":"Diabetes care"},{"issue":"3","key":"pmed.1002957.ref010","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1210\/en.2008-1795","article-title":"Minireview: Thyrotropin-releasing hormone and the thyroid hormone feedback mechanism","volume":"150","author":"MI Chiamolera","year":"2009","journal-title":"Endocrinology"},{"issue":"8","key":"pmed.1002957.ref011","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1210\/jc.2017-00410","article-title":"Defining Optimal Health Range for Thyroid Function Based on the Risk of Cardiovascular Disease","volume":"102","author":"L Chaker","year":"2017","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"9","key":"pmed.1002957.ref012","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1210\/jc.2005-0455","article-title":"The evidence for a narrower thyrotropin reference range is compelling","volume":"90","author":"L Wartofsky","year":"2005","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"1","key":"pmed.1002957.ref013","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12916-016-0693-4","article-title":"Thyroid function and risk of type 2 diabetes: a population-based prospective cohort study","volume":"14","author":"L Chaker","year":"2016","journal-title":"BMC Med"},{"issue":"12","key":"pmed.1002957.ref014","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1210\/jc.2016-2104","article-title":"Thyroid Function and Cancer Risk: The Rotterdam Study","volume":"101","author":"SR Khan","year":"2016","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"5","key":"pmed.1002957.ref015","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1530\/eje.1.02136","article-title":"Is there a need to redefine the upper normal limit of TSH?","volume":"154","author":"G Brabant","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"pmed.1002957.ref016","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1530\/EJE-16-0537","article-title":"The association of thyroid function and the risk of kidney function decline: a population-based cohort study","volume":"175","author":"L Chaker","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"pmed.1002957.ref017","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1210\/jc.2014-3586","article-title":"Thyroid function in the euthyroid range and adverse outcomes in older adults","volume":"100","author":"AR Cappola","year":"2015","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"12","key":"pmed.1002957.ref018","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.117.311603","article-title":"Thyroid Function and the Risk of Atherosclerotic Cardiovascular Morbidity and Mortality: The Rotterdam Study","volume":"121","author":"A Bano","year":"2017","journal-title":"Circ Res"},{"issue":"8","key":"pmed.1002957.ref019","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1210\/jc.2016-1300","article-title":"Thyroid Function and the Risk of Nonalcoholic Fatty Liver Disease: The Rotterdam Study","volume":"101","author":"A Bano","year":"2016","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"9","key":"pmed.1002957.ref020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S2213-8587(18)30028-7","article-title":"Clinical aspects of thyroid function during ageing","volume":"6","author":"L Chaker","year":"2018","journal-title":"The lancet Diabetes & endocrinology"},{"issue":"9","key":"pmed.1002957.ref021","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1210\/jc.2013-1315","article-title":"Clinical review: A review of the clinical consequences of variation in thyroid function within the reference range","volume":"98","author":"PN Taylor","year":"2013","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"11","key":"pmed.1002957.ref022","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1001\/jamainternmed.2017.4836","article-title":"Association of Thyroid Function With Life Expectancy With and Without Cardiovascular Disease","volume":"177","author":"A Bano","year":"2017","journal-title":"The Rotterdam Study. JAMA Intern Med"},{"issue":"9789","key":"pmed.1002957.ref023","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(11)60879-9","article-title":"UN High-Level Meeting on Non-Communicable Diseases: addressing four questions","volume":"378","author":"R Beaglehole","year":"2011","journal-title":"Lancet"},{"issue":"9","key":"pmed.1002957.ref024","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10654-017-0321-4","article-title":"The Rotterdam Study: 2018 update on objectives, design and main results","volume":"32","author":"MA Ikram","year":"2017","journal-title":"European journal of epidemiology"},{"issue":"3","key":"pmed.1002957.ref025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10654-012-9668-8","article-title":"Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study","volume":"27","author":"MJ Leening","year":"2012","journal-title":"European journal of epidemiology"},{"issue":"4","key":"pmed.1002957.ref026","doi-asserted-by":"crossref","first-page":"e1001634","DOI":"10.1371\/journal.pmed.1001634","article-title":"Modifiable etiological factors and the burden of stroke from the Rotterdam study: a population-based cohort study","volume":"11","author":"MJ Bos","year":"2014","journal-title":"PLoS Med"},{"issue":"11","key":"pmed.1002957.ref027","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/eurheartj\/ehi204","article-title":"Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology","volume":"26","author":"K Swedberg","year":"2005","journal-title":"Eur Heart J"},{"issue":"1","key":"pmed.1002957.ref028","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S2213-8587(15)00362-9","article-title":"Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study","volume":"4","author":"S Ligthart","year":"2016","journal-title":"The lancet Diabetes & endocrinology"},{"issue":"14","key":"pmed.1002957.ref029","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.ejca.2014.06.019","article-title":"Detection bias may be the main cause of increased cancer incidence among diabetics: results from the Rotterdam Study","volume":"50","author":"KM De Bruijn","year":"2014","journal-title":"Eur J Cancer"},{"issue":"1","key":"pmed.1002957.ref030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"LA Inker","year":"2012","journal-title":"The New England journal of medicine"},{"issue":"10","key":"pmed.1002957.ref031","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/clinchem\/38.10.1933","article-title":"Serum creatinine as an index of renal function: new insights into old concepts","volume":"38","author":"RD Perrone","year":"1992","journal-title":"Clinical chemistry"},{"issue":"4","key":"pmed.1002957.ref032","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"187","author":"J Vestbo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"pmed.1002957.ref033","first-page":"458","article-title":"A cardiovascular life history. A life course analysis of the original Framingham Heart Study cohort","volume":"23","author":"A Peeters","year":"2002","journal-title":"Eur Heart J"},{"issue":"20","key":"pmed.1002957.ref034","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1001\/archinte.165.20.2355","article-title":"Effects of physical activity on life expectancy with cardiovascular disease","volume":"165","author":"OH Franco","year":"2005","journal-title":"Archives of internal medicine"},{"issue":"11","key":"pmed.1002957.ref035","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/archinte.167.11.1145","article-title":"Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease","volume":"167","author":"OH Franco","year":"2007","journal-title":"Arch Intern Med"},{"key":"pmed.1002957.ref036","author":"B Efron","year":"1993"},{"issue":"4","key":"pmed.1002957.ref037","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1530\/EJE-13-0306","article-title":"Higher free thyroxine levels are associated with all-cause mortality in euthyroid older men: the Health In Men Study","volume":"169","author":"BB Yeap","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"21","key":"pmed.1002957.ref038","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1001\/jama.292.21.2591","article-title":"Thyroid status, disability and cognitive function, and survival in old age","volume":"292","author":"J Gussekloo","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"pmed.1002957.ref039","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1210\/jcem.87.3.8165","article-title":"Narrow individual variations in serum T(4) and T(3) in normal patients: a clue to the understanding of subclinical thyroid disease","volume":"87","author":"S Andersen","year":"2002","journal-title":"The Journal of clinical endocrinology and metabolism"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002957","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T03:20:59Z","timestamp":1611631259000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002957"}},"subtitle":[],"editor":[{"given":"Ronald Ching Wan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":39,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002957","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]}}}